Clinical Trial Update: Induction High-Low Dose Radiotherapy Plus Anti-PD-1 Followed by Definitive Radiotherapy in Recurrent Nasopharyngeal Carcinoma (Single-Arm Phase II) [Phase 2]

View source ↗

Summary

Phase 2 single-arm trial evaluating induction high-low dose radiotherapy plus anti-PD-1 therapy followed by definitive radiotherapy for recurrent nasopharyngeal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Jiangxi Provincial Cancer Hospital | Conditions: Nasopharyngeal Carcinoma (NPC), Recurrent Nasopharyngeal Neoplasms | Phase 2 | Status: RECRUITING